214150 — KTB Special Purpose Acquisition 2 Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Market Cap
KR₩4tn
Enterprise Value
KR₩4tn
Revenue
KR₩243bn

Annual income statement for KTB Special Purpose Acquisition 2 Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	76,461	100,597	141,803	180,123	242,939
Cost of Revenue
Gross Profit	60,959	77,853	108,167	140,449	191,128
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	35,852	48,884	72,927	90,500	132,185
Operating Profit	40,609	51,713	68,876	89,622	110,754
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	39,293	55,625	96,758	93,842	127,931
Provision for Income Taxes
Net Income After Taxes	38,165	43,805	75,379	74,225	97,544
Minority Interest
Net Income Before Extraordinary Items
Net Income	38,165	43,805	75,379	74,225	97,875
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	38,165	43,805	75,379	74,225	97,875
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	589	677	800	1,152	1,654
Dividends per Share